A selective inhibitor of heme biosynthesis in endosymbiotic bacteria elicits antifilarial activity in vitro.
Identifieur interne : 003931 ( Main/Exploration ); précédent : 003930; suivant : 003932A selective inhibitor of heme biosynthesis in endosymbiotic bacteria elicits antifilarial activity in vitro.
Auteurs : Christian S. Lentz [Allemagne] ; Victoria Halls ; Jeffrey S. Hannam ; Björn Niebel ; Uta Strübing ; Günter Mayer ; Achim Hoerauf ; Michael Famulok ; Kenneth M. PfarrSource :
- Chemistry & biology [ 1879-1301 ] ; 2013.
Descripteurs français
- KwdFr :
- Animaux, Antiprotozoaires (), Antiprotozoaires (pharmacologie), Antiprotozoaires (usage thérapeutique), Benzimidazoles (), Benzimidazoles (pharmacologie), Benzimidazoles (usage thérapeutique), Cinétique, Conception de médicament, Filarioidea (), Filariose lymphatique (traitement médicamenteux), Humains, Hème (biosynthèse), Magnésium (), Magnésium (métabolisme), Porphobilinogene synthase (antagonistes et inhibiteurs), Porphobilinogene synthase (métabolisme), Symbiose, Tests de criblage à haut débit, Thiophènes (), Thiophènes (pharmacologie), Thiophènes (usage thérapeutique), Wolbachia (enzymologie), Wolbachia (métabolisme).
- MESH :
- antagonistes et inhibiteurs : Porphobilinogene synthase.
- biosynthèse : Hème.
- enzymologie : Wolbachia.
- métabolisme : Magnésium, Porphobilinogene synthase, Wolbachia.
- pharmacologie : Antiprotozoaires, Benzimidazoles, Thiophènes.
- traitement médicamenteux : Filariose lymphatique.
- usage thérapeutique : Antiprotozoaires, Benzimidazoles, Thiophènes.
- Animaux, Antiprotozoaires, Benzimidazoles, Cinétique, Conception de médicament, Filarioidea, Humains, Magnésium, Symbiose, Tests de criblage à haut débit, Thiophènes.
English descriptors
- KwdEn :
- Animals, Antiprotozoal Agents (chemistry), Antiprotozoal Agents (pharmacology), Antiprotozoal Agents (therapeutic use), Benzimidazoles (chemistry), Benzimidazoles (pharmacology), Benzimidazoles (therapeutic use), Drug Design, Elephantiasis, Filarial (drug therapy), Filarioidea (drug effects), Heme (biosynthesis), High-Throughput Screening Assays, Humans, Kinetics, Magnesium (chemistry), Magnesium (metabolism), Porphobilinogen Synthase (antagonists & inhibitors), Porphobilinogen Synthase (metabolism), Symbiosis, Thiophenes (chemistry), Thiophenes (pharmacology), Thiophenes (therapeutic use), Wolbachia (enzymology), Wolbachia (metabolism).
- MESH :
- chemical , antagonists & inhibitors : Porphobilinogen Synthase.
- chemical , biosynthesis : Heme.
- chemical , chemistry : Antiprotozoal Agents, Benzimidazoles, Magnesium, Thiophenes.
- chemical , metabolism : Magnesium, Porphobilinogen Synthase.
- chemical , pharmacology : Antiprotozoal Agents, Benzimidazoles, Thiophenes.
- chemical , therapeutic use : Antiprotozoal Agents, Benzimidazoles, Thiophenes.
- drug effects : Filarioidea.
- drug therapy : Elephantiasis, Filarial.
- enzymology : Wolbachia.
- metabolism : Wolbachia.
- Animals, Drug Design, High-Throughput Screening Assays, Humans, Kinetics, Symbiosis.
Abstract
Lymphatic filariasis and onchocerciasis are severe diseases caused by filarial worms and affect more than 150 million people worldwide. Endosymbiotic α-proteobacteria Wolbachia are essential for these parasites throughout their life cycle. Using a high-throughput chemical screen, we identified a benzimidazole compound, wALADin1, that selectively targets the δ-aminolevulinic acid dehydratase (ALAD) of Wolbachia (wALAD) and exhibits macrofilaricidal effects on Wolbachia-containing filarial worms in vitro. wALADin1 is a mixed competitive/noncompetitive inhibitor that interferes with the Mg(2+)-induced activation of wALAD. This mechanism inherently excludes activity against the Zn(2+)-dependent human ortholog and might be translatable to Mg(2+)-responsive orthologs of other bacterial or protozoan pathogens. The specificity profile of wALADin1 derivatives reveals chemical features responsible for inhibitory potency and species selectivity. Our findings validate wALADins as a basis for developing potent leads that meet current requirements for antifilarial drugs.
DOI: 10.1016/j.chembiol.2012.11.009
PubMed: 23438747
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 001C86
- to stream PubMed, to step Curation: 001C86
- to stream PubMed, to step Checkpoint: 001C86
- to stream Ncbi, to step Merge: 005648
- to stream Ncbi, to step Curation: 005648
- to stream Ncbi, to step Checkpoint: 005648
- to stream Main, to step Merge: 003940
- to stream Main, to step Curation: 003931
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">A selective inhibitor of heme biosynthesis in endosymbiotic bacteria elicits antifilarial activity in vitro.</title>
<author><name sortKey="Lentz, Christian S" sort="Lentz, Christian S" uniqKey="Lentz C" first="Christian S" last="Lentz">Christian S. Lentz</name>
<affiliation wicri:level="3"><nlm:affiliation>Institute of Medical Microbiology, Immunology and Parasitology, University Hospital Bonn, Sigmund-Freud Strasse 25, 53127 Bonn, Germany.</nlm:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Institute of Medical Microbiology, Immunology and Parasitology, University Hospital Bonn, Sigmund-Freud Strasse 25, 53127 Bonn</wicri:regionArea>
<placeName><region type="land" nuts="1">Rhénanie-du-Nord-Westphalie</region>
<region type="district" nuts="2">District de Cologne</region>
<settlement type="city">Bonn</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Halls, Victoria" sort="Halls, Victoria" uniqKey="Halls V" first="Victoria" last="Halls">Victoria Halls</name>
</author>
<author><name sortKey="Hannam, Jeffrey S" sort="Hannam, Jeffrey S" uniqKey="Hannam J" first="Jeffrey S" last="Hannam">Jeffrey S. Hannam</name>
</author>
<author><name sortKey="Niebel, Bjorn" sort="Niebel, Bjorn" uniqKey="Niebel B" first="Björn" last="Niebel">Björn Niebel</name>
</author>
<author><name sortKey="Strubing, Uta" sort="Strubing, Uta" uniqKey="Strubing U" first="Uta" last="Strübing">Uta Strübing</name>
</author>
<author><name sortKey="Mayer, Gunter" sort="Mayer, Gunter" uniqKey="Mayer G" first="Günter" last="Mayer">Günter Mayer</name>
</author>
<author><name sortKey="Hoerauf, Achim" sort="Hoerauf, Achim" uniqKey="Hoerauf A" first="Achim" last="Hoerauf">Achim Hoerauf</name>
</author>
<author><name sortKey="Famulok, Michael" sort="Famulok, Michael" uniqKey="Famulok M" first="Michael" last="Famulok">Michael Famulok</name>
</author>
<author><name sortKey="Pfarr, Kenneth M" sort="Pfarr, Kenneth M" uniqKey="Pfarr K" first="Kenneth M" last="Pfarr">Kenneth M. Pfarr</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2013">2013</date>
<idno type="RBID">pubmed:23438747</idno>
<idno type="pmid">23438747</idno>
<idno type="doi">10.1016/j.chembiol.2012.11.009</idno>
<idno type="wicri:Area/PubMed/Corpus">001C86</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001C86</idno>
<idno type="wicri:Area/PubMed/Curation">001C86</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001C86</idno>
<idno type="wicri:Area/PubMed/Checkpoint">001C86</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">001C86</idno>
<idno type="wicri:Area/Ncbi/Merge">005648</idno>
<idno type="wicri:Area/Ncbi/Curation">005648</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">005648</idno>
<idno type="wicri:Area/Main/Merge">003940</idno>
<idno type="wicri:Area/Main/Curation">003931</idno>
<idno type="wicri:Area/Main/Exploration">003931</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">A selective inhibitor of heme biosynthesis in endosymbiotic bacteria elicits antifilarial activity in vitro.</title>
<author><name sortKey="Lentz, Christian S" sort="Lentz, Christian S" uniqKey="Lentz C" first="Christian S" last="Lentz">Christian S. Lentz</name>
<affiliation wicri:level="3"><nlm:affiliation>Institute of Medical Microbiology, Immunology and Parasitology, University Hospital Bonn, Sigmund-Freud Strasse 25, 53127 Bonn, Germany.</nlm:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Institute of Medical Microbiology, Immunology and Parasitology, University Hospital Bonn, Sigmund-Freud Strasse 25, 53127 Bonn</wicri:regionArea>
<placeName><region type="land" nuts="1">Rhénanie-du-Nord-Westphalie</region>
<region type="district" nuts="2">District de Cologne</region>
<settlement type="city">Bonn</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Halls, Victoria" sort="Halls, Victoria" uniqKey="Halls V" first="Victoria" last="Halls">Victoria Halls</name>
</author>
<author><name sortKey="Hannam, Jeffrey S" sort="Hannam, Jeffrey S" uniqKey="Hannam J" first="Jeffrey S" last="Hannam">Jeffrey S. Hannam</name>
</author>
<author><name sortKey="Niebel, Bjorn" sort="Niebel, Bjorn" uniqKey="Niebel B" first="Björn" last="Niebel">Björn Niebel</name>
</author>
<author><name sortKey="Strubing, Uta" sort="Strubing, Uta" uniqKey="Strubing U" first="Uta" last="Strübing">Uta Strübing</name>
</author>
<author><name sortKey="Mayer, Gunter" sort="Mayer, Gunter" uniqKey="Mayer G" first="Günter" last="Mayer">Günter Mayer</name>
</author>
<author><name sortKey="Hoerauf, Achim" sort="Hoerauf, Achim" uniqKey="Hoerauf A" first="Achim" last="Hoerauf">Achim Hoerauf</name>
</author>
<author><name sortKey="Famulok, Michael" sort="Famulok, Michael" uniqKey="Famulok M" first="Michael" last="Famulok">Michael Famulok</name>
</author>
<author><name sortKey="Pfarr, Kenneth M" sort="Pfarr, Kenneth M" uniqKey="Pfarr K" first="Kenneth M" last="Pfarr">Kenneth M. Pfarr</name>
</author>
</analytic>
<series><title level="j">Chemistry & biology</title>
<idno type="eISSN">1879-1301</idno>
<imprint><date when="2013" type="published">2013</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Animals</term>
<term>Antiprotozoal Agents (chemistry)</term>
<term>Antiprotozoal Agents (pharmacology)</term>
<term>Antiprotozoal Agents (therapeutic use)</term>
<term>Benzimidazoles (chemistry)</term>
<term>Benzimidazoles (pharmacology)</term>
<term>Benzimidazoles (therapeutic use)</term>
<term>Drug Design</term>
<term>Elephantiasis, Filarial (drug therapy)</term>
<term>Filarioidea (drug effects)</term>
<term>Heme (biosynthesis)</term>
<term>High-Throughput Screening Assays</term>
<term>Humans</term>
<term>Kinetics</term>
<term>Magnesium (chemistry)</term>
<term>Magnesium (metabolism)</term>
<term>Porphobilinogen Synthase (antagonists & inhibitors)</term>
<term>Porphobilinogen Synthase (metabolism)</term>
<term>Symbiosis</term>
<term>Thiophenes (chemistry)</term>
<term>Thiophenes (pharmacology)</term>
<term>Thiophenes (therapeutic use)</term>
<term>Wolbachia (enzymology)</term>
<term>Wolbachia (metabolism)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Animaux</term>
<term>Antiprotozoaires ()</term>
<term>Antiprotozoaires (pharmacologie)</term>
<term>Antiprotozoaires (usage thérapeutique)</term>
<term>Benzimidazoles ()</term>
<term>Benzimidazoles (pharmacologie)</term>
<term>Benzimidazoles (usage thérapeutique)</term>
<term>Cinétique</term>
<term>Conception de médicament</term>
<term>Filarioidea ()</term>
<term>Filariose lymphatique (traitement médicamenteux)</term>
<term>Humains</term>
<term>Hème (biosynthèse)</term>
<term>Magnésium ()</term>
<term>Magnésium (métabolisme)</term>
<term>Porphobilinogene synthase (antagonistes et inhibiteurs)</term>
<term>Porphobilinogene synthase (métabolisme)</term>
<term>Symbiose</term>
<term>Tests de criblage à haut débit</term>
<term>Thiophènes ()</term>
<term>Thiophènes (pharmacologie)</term>
<term>Thiophènes (usage thérapeutique)</term>
<term>Wolbachia (enzymologie)</term>
<term>Wolbachia (métabolisme)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="antagonists & inhibitors" xml:lang="en"><term>Porphobilinogen Synthase</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="biosynthesis" xml:lang="en"><term>Heme</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="chemistry" xml:lang="en"><term>Antiprotozoal Agents</term>
<term>Benzimidazoles</term>
<term>Magnesium</term>
<term>Thiophenes</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en"><term>Magnesium</term>
<term>Porphobilinogen Synthase</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="pharmacology" xml:lang="en"><term>Antiprotozoal Agents</term>
<term>Benzimidazoles</term>
<term>Thiophenes</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Antiprotozoal Agents</term>
<term>Benzimidazoles</term>
<term>Thiophenes</term>
</keywords>
<keywords scheme="MESH" qualifier="antagonistes et inhibiteurs" xml:lang="fr"><term>Porphobilinogene synthase</term>
</keywords>
<keywords scheme="MESH" qualifier="biosynthèse" xml:lang="fr"><term>Hème</term>
</keywords>
<keywords scheme="MESH" qualifier="drug effects" xml:lang="en"><term>Filarioidea</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Elephantiasis, Filarial</term>
</keywords>
<keywords scheme="MESH" qualifier="enzymologie" xml:lang="fr"><term>Wolbachia</term>
</keywords>
<keywords scheme="MESH" qualifier="enzymology" xml:lang="en"><term>Wolbachia</term>
</keywords>
<keywords scheme="MESH" qualifier="metabolism" xml:lang="en"><term>Wolbachia</term>
</keywords>
<keywords scheme="MESH" qualifier="métabolisme" xml:lang="fr"><term>Magnésium</term>
<term>Porphobilinogene synthase</term>
<term>Wolbachia</term>
</keywords>
<keywords scheme="MESH" qualifier="pharmacologie" xml:lang="fr"><term>Antiprotozoaires</term>
<term>Benzimidazoles</term>
<term>Thiophènes</term>
</keywords>
<keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Filariose lymphatique</term>
</keywords>
<keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Antiprotozoaires</term>
<term>Benzimidazoles</term>
<term>Thiophènes</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Animals</term>
<term>Drug Design</term>
<term>High-Throughput Screening Assays</term>
<term>Humans</term>
<term>Kinetics</term>
<term>Symbiosis</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Animaux</term>
<term>Antiprotozoaires</term>
<term>Benzimidazoles</term>
<term>Cinétique</term>
<term>Conception de médicament</term>
<term>Filarioidea</term>
<term>Humains</term>
<term>Magnésium</term>
<term>Symbiose</term>
<term>Tests de criblage à haut débit</term>
<term>Thiophènes</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Lymphatic filariasis and onchocerciasis are severe diseases caused by filarial worms and affect more than 150 million people worldwide. Endosymbiotic α-proteobacteria Wolbachia are essential for these parasites throughout their life cycle. Using a high-throughput chemical screen, we identified a benzimidazole compound, wALADin1, that selectively targets the δ-aminolevulinic acid dehydratase (ALAD) of Wolbachia (wALAD) and exhibits macrofilaricidal effects on Wolbachia-containing filarial worms in vitro. wALADin1 is a mixed competitive/noncompetitive inhibitor that interferes with the Mg(2+)-induced activation of wALAD. This mechanism inherently excludes activity against the Zn(2+)-dependent human ortholog and might be translatable to Mg(2+)-responsive orthologs of other bacterial or protozoan pathogens. The specificity profile of wALADin1 derivatives reveals chemical features responsible for inhibitory potency and species selectivity. Our findings validate wALADins as a basis for developing potent leads that meet current requirements for antifilarial drugs.</div>
</front>
</TEI>
<affiliations><list><country><li>Allemagne</li>
</country>
<region><li>District de Cologne</li>
<li>Rhénanie-du-Nord-Westphalie</li>
</region>
<settlement><li>Bonn</li>
</settlement>
</list>
<tree><noCountry><name sortKey="Famulok, Michael" sort="Famulok, Michael" uniqKey="Famulok M" first="Michael" last="Famulok">Michael Famulok</name>
<name sortKey="Halls, Victoria" sort="Halls, Victoria" uniqKey="Halls V" first="Victoria" last="Halls">Victoria Halls</name>
<name sortKey="Hannam, Jeffrey S" sort="Hannam, Jeffrey S" uniqKey="Hannam J" first="Jeffrey S" last="Hannam">Jeffrey S. Hannam</name>
<name sortKey="Hoerauf, Achim" sort="Hoerauf, Achim" uniqKey="Hoerauf A" first="Achim" last="Hoerauf">Achim Hoerauf</name>
<name sortKey="Mayer, Gunter" sort="Mayer, Gunter" uniqKey="Mayer G" first="Günter" last="Mayer">Günter Mayer</name>
<name sortKey="Niebel, Bjorn" sort="Niebel, Bjorn" uniqKey="Niebel B" first="Björn" last="Niebel">Björn Niebel</name>
<name sortKey="Pfarr, Kenneth M" sort="Pfarr, Kenneth M" uniqKey="Pfarr K" first="Kenneth M" last="Pfarr">Kenneth M. Pfarr</name>
<name sortKey="Strubing, Uta" sort="Strubing, Uta" uniqKey="Strubing U" first="Uta" last="Strübing">Uta Strübing</name>
</noCountry>
<country name="Allemagne"><region name="Rhénanie-du-Nord-Westphalie"><name sortKey="Lentz, Christian S" sort="Lentz, Christian S" uniqKey="Lentz C" first="Christian S" last="Lentz">Christian S. Lentz</name>
</region>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003931 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 003931 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Sante |area= LymphedemaV1 |flux= Main |étape= Exploration |type= RBID |clé= pubmed:23438747 |texte= A selective inhibitor of heme biosynthesis in endosymbiotic bacteria elicits antifilarial activity in vitro. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:23438747" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \ | NlmPubMed2Wicri -a LymphedemaV1
This area was generated with Dilib version V0.6.31. |